Written and maintained by CASRAI Editorial Board
Last updated
A therapy intake form (also called a counseling intake form or behavioral health intake questionnaire) is the foundational pre-session clinical instrument completed by a client prior to an initial psychotherapy or psychiatric diagnostic evaluation (billed under CPT code 90791 for an integrated biopsychosocial assessment without medical services, or 90792 with medical services). Distinct from a general ambulatory patient intake packet or a musculoskeletal physical therapy (PT) intake form, a behavioral health therapy intake form captures the longitudinal biopsychosocial history, acute safety and suicide risk screening, standardized Measurement-Based Care (MBC) symptom severity baselines, and psychotherapy-specific informed consent disclosures required before initiating clinical treatment or enrolling a participant in a behavioral health clinical trial.
In modern behavioral health informatics, digital therapy intake packets are authored as structured HL7 FHIR R4 Questionnaire resources paired with LOINC-coded psychometric instruments, feeding discrete baseline scores directly into the clinician’s initial diagnostic formulation and ongoing mental health SOAP notes.
What Should Be Included in a Therapy Intake Form? (7 Core Clinical Domains)
Aligned with the American Psychiatric Association Practice Guidelines for the Psychiatric Evaluation of Adults and American Psychological Association (APA) record-keeping guidelines, a complete counseling or psychotherapy intake packet comprises seven clinical and regulatory domains:
| Intake Section | Essential Data Elements Captured | Clinical & Regulatory Purpose |
|---|---|---|
| 1. Demographics & Telehealth Safety Verification | Legal name, chosen name, pronouns, DOB, physical address at time of session, emergency contact name/phone, and local emergency services authorization | Verifies clinician state licensure jurisdiction and establishes an emergency dispatch protocol for telehealth crisis escalation |
| 2. Presenting Problem & Treatment Goals | Client’s chief complaint in their own words, onset/precipitating stressors, functional impairment in work/school/relationships, and desired therapy outcomes | Establishes medical necessity and anchors collaborative treatment planning |
| 3. Psychiatric & Behavioral Health History | Prior outpatient psychotherapy, past psychiatric diagnoses, psychiatric hospitalizations or crisis stabilization visits, and current/past psychotropic medications | Identifies treatment-resistant trajectories, prior therapeutic alliance patterns, and medication adherence |
| 4. Acute Safety & Suicide Risk Screening | Passive death wishes, active suicidal ideation, intent, plan, preparatory behavior, past suicide attempts (C-SSRS), non-suicidal self-injury (NSSI), and harm to others | Triggers immediate clinical safety planning (Stanley-Brown Safety Plan) or crisis intervention prior to or at the start of the intake visit |
| 5. Biopsychosocial & Substance Use Assessment | Medical comorbidities, primary care provider, sleep/appetite/energy changes, alcohol/substance use (AUDIT-C / DAST-10), developmental/trauma history, and family psychiatric history | Rules out organic/medical mimics of psychiatric symptoms (e.g., thyroid dysfunction, sleep apnea) and maps social determinants of health |
| 6. Baseline Measurement-Based Care (MBC) Scales | Standardized validated self-report symptom questionnaires such as PHQ-9 (depression), GAD-7 (anxiety), and PCL-5 (PTSD) | Provides quantitative baseline severity scores for DSM-5-TR formulation and longitudinal treatment response tracking |
| 7. Psychotherapy Informed Consent & Privacy | Therapeutic modality overview, limits of confidentiality (mandated reporting of child/elder abuse, Tarasoff duty to warn/protect), HIPAA Notice of Privacy Practices, and No Surprises Act Good Faith Estimate | Satisfies state licensing board ethical mandates, HIPAA 45 CFR Part 164, and 45 CFR § 149.610 (Good Faith Estimates for uninsured/self-pay clients) |
Standardized Measurement-Based Care (MBC) Instruments and LOINC Mapping
Integrating validated patient-reported outcome measures (PROMs) into the therapy intake form enables objective baseline stratification and fulfills quality reporting measures (such as CMS MIPS Measure #370, Depression Remission at Twelve Months). In EHR systems supporting HL7 FHIR US Core, intake scales are mapped to standardized LOINC panel and total-score codes:
- Patient Health Questionnaire-9 (PHQ-9): 9-item DSM-5-TR depressive symptom severity scale scored 0–27 (0–4 Minimal, 5–9 Mild, 10–14 Moderate, 15–19 Moderately Severe, 20–27 Severe; Item 9 screens specifically for thoughts of self-harm or being better off dead). Mapped to LOINC Panel
44249-1and Total Score44261-6. - Generalized Anxiety Disorder-7 (GAD-7): 7-item anxiety severity scale scored 0–21 (0–4 Minimal, 5–9 Mild, 10–14 Moderate, 15–21 Severe). Mapped to LOINC Panel
69737-5and Total Score70274-6. - Columbia-Suicide Severity Rating Scale (C-SSRS) Screener: 6-item structured suicide risk screening tool stratifying ideation severity and recent suicidal behavior into Low, Moderate, or High acute risk tiers (LOINC Panel
93373-9). - AUDIT-C / DAST-10: Alcohol Use Disorders Identification Test-Consumption (LOINC Panel
72109-2, total score75626-2) and Drug Abuse Screening Test to identify co-occurring substance use disorders.
Privacy Governance: HIPAA Designated Record Set vs. Psychotherapy Notes vs. 42 CFR Part 2
A frequent compliance error in behavioral health practice is assuming that a completed therapy intake form is legally protected as a “psychotherapy note” under HIPAA:
- Intake Forms Are Part of the Designated Record Set (Not Psychotherapy Notes): Under 45 CFR § 164.501, HIPAA’s special protection for psychotherapy notes (45 CFR § 164.508(a)(2)) applies strictly to a clinician’s private process notes analyzing the contents of a counseling conversation that are kept physically or electronically segregated from the rest of the medical record. Structured therapy intake forms, biopsychosocial histories, medication lists, PHQ-9/GAD-7 scores, DSM-5-TR diagnoses, treatment plans, and session start/stop times are part of the standard Designated Record Set and are subject to patient right-of-access and Cures Act EHI rules.
- Substance Use Disorder (SUD) Intake Records Under 42 CFR Part 2: When a therapy intake form is collected by a federally assisted Substance Use Disorder (SUD) treatment program (a “Part 2 Program”), any intake data identifying the client as having or seeking treatment for a substance use disorder is protected by 42 CFR Part 2. Under the 2024 HHS Part 2 Final Rule (aligning 42 U.S.C. § 290dd-2 with the CARES Act), a patient may sign a single broad consent for all future uses and disclosures for Treatment, Payment, and Health Care Operations (TPO), while SUD Counseling Notes (the Part 2 equivalent of psychotherapy notes) require a separate specific consent.
How a Therapy Intake Form Is Structured in EHR and HL7 FHIR Workflows
In cloud EHRs and decentralized behavioral health trials, the therapy intake workflow executes across three automated stages using the HL7 FHIR R4 Structured Data Capture (SDC) specification:
- Pre-Visit Dispatch (
Task&Questionnaire): Upon scheduling a CPT 90791 diagnostic intake, the EHR generates a patient portal or SMS link rendering the FHIRQuestionnaireresource with conditional branching logic (enableWhen)—for example, displaying follow-up suicide safety questions only if PHQ-9 Item 9 or C-SSRS Item 2 is answered affirmatively. - Real-Time Safety Alerting: When the client submits the
QuestionnaireResponse, server-side scoring expressions evaluate PHQ-9 Item 9 and C-SSRS items immediately. If an acute safety threshold is triggered prior to the appointment, the platform displays crisis hotlines (such as the 988 Suicide & Crisis Lifeline) to the client and alerts the intake clinician. - Automated Resource Extraction (
SDC Extract): The EHR transforms discreteQuestionnaireResponseitems into FHIRObservationresources (PHQ-9, GAD-7, social history),MedicationStatementresources, and draft problem list entries inside the CPT 90791 initial evaluation note.
Copy-Ready Therapy Intake Form Template and Worked Example
Blank Psychotherapy / Counseling Intake Form Template
SECTION 1: CLIENT INFORMATION & TELEHEALTH EMERGENCY PROTOCOL- Legal Name: ___________________ Chosen Name / Pronouns: _______________ DOB: __________- Physical Address During Sessions: ______________________________________________________- Phone: ________________________ Email (Portal Consent: Yes / No): ______________________- Emergency Contact Name, Relationship & Phone: __________________________________________SECTION 2: PRESENTING CONCERNS & GOALS FOR THERAPY1. In your own words, what brings you to therapy at this time? ___________________________2. When did these concerns begin, and have any recent life events affected them? _________3. How are these symptoms affecting your daily work/school, sleep, or relationships? _____4. What are your top 2-3 goals for our work together? ___________________________________SECTION 3: MENTAL HEALTH & MEDICAL HISTORY- Prior Psychotherapy / Counseling (Dates, Provider, What Was Helpful): __________________- Prior Psychiatric Hospitalizations or Intensive Outpatient Programs (Dates/Facility): ___- Current & Past Psychiatric Medications (Medication, Dose, Prescriber, Response): _______- Primary Care Provider & Current Medical Conditions / Allergies: ________________________- Family History of Mental Health or Substance Use Conditions: ___________________________SECTION 4: BIOPSYCHOSOCIAL, LIFESTYLE & SUBSTANCE SCREENING- Sleep (Avg hours/night, trouble falling/staying asleep): _______________________________- Appetite / Energy Changes: _____________________________________________________________- Living Situation, Occupation & Social Support Network: _________________________________- Alcohol, Tobacco/Nicotine, Cannabis, or Other Substance Use (Frequency/Amount): ________SECTION 5: SAFETY & RISK SCREENING- In the past month, have you wished you were dead or had thoughts of hurting yourself? [ ] No [ ] Yes- Have you ever attempted suicide or engaged in non-suicidal self-injury? [ ] No [ ] Yes- Do you currently feel unsafe in your home or relationships? [ ] No [ ] YesSECTION 6: BASELINE SYMPTOM SCALES (PAST 2 WEEKS: 0=Not at all, 1=Several days, 2=More than half the days, 3=Nearly every day)- PHQ-9 Total Score: ____ / 27 - GAD-7 Total Score: ____ / 21SECTION 7: INFORMED CONSENT & PRIVACY ACKNOWLEDGMENTI understand the scope of psychotherapy, fee/cancellation policies, and the legal limits of confidentiality (including mandatory reporting of suspected child/elder/dependent adult abuse and imminent risk of serious harm to self or others).Client / Legal Guardian Signature: ___________________________ Date: _______________Worked Clinical Intake Summary Example (CPT 90791 EHR Pre-Population)
Client: 29-year-old female presenting for initial outpatient telehealth psychotherapy evaluation (physical location verified at home address in-state; emergency contact: spouse, phone verified). Chief Complaint: “Over the past four months I have had constant worry, chest tightness before work meetings, and difficulty sleeping more than four hours a night.” Psychiatric History: One prior episode of adjustment disorder with anxious mood in college (treated with 12 sessions of CBT, full remission); no prior psychiatric hospitalizations; no current psychotropic medications. Medical & Biopsychosocial: Recent thyroid panel (TSH 1.8 mIU/L) and CBC within normal limits via PCP 3 weeks ago; caffeine intake 4 cups coffee/day; alcohol 1–2 drinks/month; denies tobacco or illicit substance use. Safety Screening: C-SSRS negative for passive or active suicidal ideation (0/6), lifetime attempts (0), and self-harm; PHQ-9 Item 9 = 0. Baseline MBC Scores: GAD-7 = 14/21 (Moderate anxiety severity; LOINC 70274-6); PHQ-9 = 7/27 (Mild depressive symptoms, predominantly sleep/fatigue items; LOINC 44261-6). Initial Formulation & Plan: Generalized Anxiety Disorder (DSM-5-TR / ICD-10-CM F41.1); initiate weekly individual Cognitive Behavioral Therapy (CBT) with caffeine reduction, stimulus-control sleep hygiene, and repeat GAD-7/PHQ-9 administration every 4 weeks.
Frequently Asked Questions
What should be included in a therapy intake form?
A comprehensive psychotherapy or counseling intake form includes seven core sections: (1) client demographics, emergency contact, and telehealth physical location verification; (2) presenting problem, chief complaint, and therapy goals; (3) psychiatric and mental health treatment history (prior therapy, hospitalizations, psychiatric medications); (4) suicide, self-harm, and violence risk screening (such as the C-SSRS); (5) biopsychosocial and substance use history (medical conditions, sleep/appetite, trauma history, family psychiatric history, social determinants); (6) baseline Measurement-Based Care symptom scales (PHQ-9, GAD-7); and (7) psychotherapy informed consent covering confidentiality limits, mandated reporting, and HIPAA/42 CFR Part 2 disclosures.
How is a therapy intake form structured in EHR workflows?
In behavioral health EHRs and clinical research platforms, therapy intake forms are encoded using the HL7 FHIR R4 Questionnaire and QuestionnaireResponse resources (Structured Data Capture [SDC] Implementation Guide). Standardized instruments embedded in the intake packet—such as the PHQ-9 (LOINC panel 44249-1) and GAD-7 (LOINC panel 69737-5)—are automatically scored upon submission and extracted into discrete FHIR Observation, Condition, and MedicationStatement resources to populate the initial psychiatric evaluation and longitudinal Measurement-Based Care (MBC) flowsheets.
